Abstract
Background
The frequency and predictors of hepatocellular carcinoma (HCC) within each liver imaging reporting and data system (LI-RADS) category remains unclear. We sought to estimate the cumulative frequency of HCC in LI-RADS observations of high/intermediate category and identify clinical/radiographic features associated with HCC.
Methods
Our diagnostic imaging database was searched for computed tomography/magnetic resonance imaging reports of patients with evidence of cirrhosis and liver observations. LI-RADS categories were determined by imaging review, while demographic and clinical outcomes were assigned by chart review. A composite outcome of clinical/radiographic confirmation of HCC was used. We used multivariable analysis to identify features associated with HCC, and competing risks regression to estimate the cumulative frequency of HCC in each category.
Results
Our search returned 95 patients with 137 observations (LR2 = 4, LR3 = 53, LR4 = 37, and LR5 = 43). On multivariable analysis, increasing age (hazard ratio [HR] 1.76 per 10 years, p = 0.049), washout (HR 5.34, p < 0.002), and increasing size (size < 10 mm reference, 10–20 mm, HR 3.93, p = 0.014; size > 20 mm, HR 21.69, p < 0.001) were associated with HCC. Median time to diagnosis was 6.13 months (interquartile range [IQR] 4.6–13.1), 4.7 months (IQR 2.5–14.5), and 3.6 months (IQR 1.9–6.6) for LR3, 4, and 5 category observations, respectively. The cumulative frequency of HCC was 59.8% in LR3, 84.62% in LR4, and 99.84% in LR5, at last follow-up.
Conclusion
The frequency of HCC within each LI-RADS category reflects the intended purpose, intermediate probability for LR3, probable HCC for LR4, and definite HCC for LR5.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47(1):97–104.
Mitchell DG, Bruix J, Sherman M, Sirlin CB. LI-RADS (liver imaging reporting and data system): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61(3):1056–65.
Bashir M, Chernyak V, Cui J, et al. CT/MRI LI-RADS V2017. 2017; CT and MRI LI-RADS algorithm. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CT-MRI-LI-RADS-v2017. Accessed 4 May 2018.
Tanabe M, Kanki A, Wolfson T, et al. Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology. 2016;281:152173.
Darnell A, Forner A, Rimola J, et al. Liver Imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology. 2015;275(3):698–707.
mPower Clinical Analytics for Diagnostic Imaging. 2018; Product webpage for Nuance mPower. https://www.nuance.com/healthcare/medical-imaging/mpower-clinical-analytics.html. Accessed 7 May 2018.
Fine JP, Gray RJ. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
Ronot M, Fouque O, Esvan M, Lebigot J, Aube C, Vilgrain V. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. J Hepatol. 2018;68(4):715–23.
Choi SH, Byun JH, Kim SY, et al. Liver imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol. 2016;51(8):483–90.
Burke LM, Sofue K, Alagiyawanna M, et al. Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol (NY). 2016;41(9):1758–66.
Sofue K, Burke LMB, Nilmini V, et al. Liver imaging reporting and data system category 4 observations in MRI: risk factors predicting upgrade to category 5. J Magn Reson Imaging. 2017;46(3):783–92.
Mitchell DG, Bashir MR, Sirlin CB. Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations. Abdom Radiol (NY). 2018;43(1):143–8.
Kudo M, Tochio H. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma. Oncology. 2008;75 Suppl 1:55–64.
Tang A, Bashir MR, Corwin MT, et al. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology. 2018;286(1):29–48.
Ohkawa K, Imanaka K, Sakakibara M, et al. Factors related to shift from hepatic borderline lesion to overt HCC diagnosed by CT. Hepatogastroenterology. 2014;61(134):1680–7.
Cerny M, Bergeron C, Billiard JS, et al. LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology. 2018;288:171678.
Zhao W, Li W, Yi X, et al. Diagnostic value of liver imaging reporting and data system MRI on primary hepatocellular carcinoma [in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(4):380–7.
Choi SH, Byun JH, Lim YS, et al. Liver imaging reporting and data system: patient outcomes for category 4 and 5 nodules. Radiology. 2018;287(2):515–24.
Disclosures
Ephraim Shin-Tian Tang, Grayson Hall, David Yu, Alexandre Menard, Wilma Hopman, and Sulaiman Nanji have no conflicts of interest to declare.
Funding
No specific funding sources were used for this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tang, E.ST., Hall, G., Yu, D. et al. Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution. Ann Surg Oncol 26, 2560–2567 (2019). https://doi.org/10.1245/s10434-019-07386-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07386-9